A new study reveals that higher concentrations of a specific protein in urine could be a predictor for developing dementia.

The U.S. Food and Drug Administration (FDA) has approved Gazyva® (obinutuzumab), developed by Genentech, as a treatment for adults with lupus nephritis (LN), also known as lupus-related kidney disease ...

Study reveals a ubiquitin precursor enhances cellular stress resistance and promotes longevity, offering new insights into ...

An oversubscribed seed funding round will give Procyon the financial resources it needs to launch its first diagnostic – ...

Immunotherapy with immune checkpoint inhibitors has revolutionized cancer treatment over the past decade by producing cures in many patients who were previously considered incurable. However, these ...

Pre-eclampsia is one of the most serious complications in pregnancy, affecting millions of women and newborns worldwide.

11:18, Thu, Oct 9, 2025 Updated: 11:27, Thu, Oct 9, 2025 A simple urine test could reveal your risk of developing cruel dementia, a new study claims - decades before symptoms even start to appear.

The findings position Fabhalta to secure a standard approval in IgA nephropathy — a crowded area of drug research — at a time ...

A new gene therapy approach aimed at protecting people with type 1 diabetes from developing diabetic kidney disease—a serious ...